The Clinical Core of this Program Project (PP) was established at the time of the first year of funding to recruit patients with Alzheimer's Disease and Parkinson's Disease for clinical assessment and brain tissue donation. Two existing clinical centers were organized to achieve the stated goals and specific aims at the University of Pennsylvania (UP) and the Graduate Hospital (GH). An efficient structure for evaluating patients and requesting consent for autopsy has been created.
The aims and methods described later in this section of the application represent a continuation and refinement of the broad goals of the first cycle of the PP. We will continue to recruit well studied patients and to solicit donations of brain tissue. There will be stronger emphasis on the evaluation of the neuropsychological aspects of PD. Whereas in the previous application, we concentrated on conventional clinical assessments of physical and mental features of PD, we have outlined in this application our plans to conduct a longitudinal study of the potential of a particular battery of neuropsychological tests to predict the eventual development of dementia in a cohort of PD patients over 65. Finally, we will correlate a number of clinical features of PD and AD (e.g. the distribution of Apolipoprotein E alleles) with findings at autopsy to define with greater precision criteria for Diffuse Lewy Body Disease (DLBD) and to identify markers of disease progression.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG009215-10
Application #
6098269
Study Section
Project Start
1999-06-01
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Tosto, Giuseppe; Monsell, Sarah E; Hawes, Stephen E et al. (2015) Pattern of extrapyramidal signs in Alzheimer's disease. J Neurol 262:2548-56
Paumier, Katrina L; Luk, Kelvin C; Manfredsson, Fredric P et al. (2015) Intrastriatal injection of pre-formed mouse ?-synuclein fibrils into rats triggers ?-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis 82:185-199
Kalia, Lorraine V; Lang, Anthony E; Hazrati, Lili-Naz et al. (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100-5
Mata, Ignacio F; Leverenz, James B; Weintraub, Daniel et al. (2014) APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol 71:1405-12
Motsinger-Reif, Alison A; Zhu, Hongjie; Kling, Mitchel A et al. (2013) Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging. Acta Neuropathol Commun 1:28
Arnold, Steven E; Toledo, Jon B; Appleby, Dina H et al. (2013) Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. J Comp Neurol 521:4339-55
Kaddurah-Daouk, R; Zhu, H; Sharma, S et al. (2013) Alterations in metabolic pathways and networks in Alzheimer's disease. Transl Psychiatry 3:e244
Couthouis, Julien; Hart, Michael P; Erion, Renske et al. (2012) Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet 21:2899-911
Hu, William T; Holtzman, David M; Fagan, Anne M et al. (2012) Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79:897-905
Chen-Plotkin, Alice S; Unger, Travis L; Gallagher, Michael D et al. (2012) TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J Neurosci 32:11213-27

Showing the most recent 10 out of 208 publications